Inventiva (IVA) Asset Utilization Ratio (2021)

Inventiva (IVA) recorded quarterly Asset Utilization Ratio of 0.0 in Q2 2021.

Inventiva (IVA) Asset Utilization Ratio (2021) Analysis & Trends

Inventiva's Asset Utilization Ratio history runs 1 years deep, the most recent figure standing at 0.0 for Q2 2021.

In Q2 2021, Asset Utilization Ratio changed N/A year-over-year to 0.0; the TTM figure through Jun 2021 stood at 0.0 (changed N/A YoY), while the FY2025 annual figure was 0.02, down 74.32% from the prior year.
Asset Utilization Ratio was 0.0 for Q2 2021 at Inventiva.
In the past five years, Asset Utilization Ratio ranged from a high of 0.0 in Q2 2021 to a low of 0.0 in Q2 2021.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Alterity Therapeutics	719,706.53 Bn	719,706.50 Bn	-	0.55
2	Belite Bio	55,800.00 Bn	55,800.00 Bn	-	-
3	Quantum Biopharma	18,182.30 Bn	18,182.29 Bn	-	-
4	Legend Biotech	3,154.00 Bn	3,153.71 Bn	242.10 Mn	0.60
5	Akari Therapeutics	1,844.30 Bn	1,844.29 Bn	-	-
6	Evaxion A	1,567.96 Bn	1,567.94 Bn	-	1,422.00
7	Psyence Biomedical	251.43 Bn	251.42 Bn	-	-
8	Vertex Pharmaceuticals	112.56 Bn	105.31 Bn	2.59 Bn	0.47
9	Abivax	94.37 Bn	94.37 Bn	-	-
10	Inventiva	8.78 Mn	-259.95 Mn	-	-

Historic Data

Download Data

Date	Value
Jun 30, 2021	0.00